Search Results - cardiovascular

10 Results Sort By:
Advanced Electromagnetic Catheter Tracking System for Fluoroscopic and Three-Dimensional Echocardiography
MUSC inventors have developed new systems and methods for image-guided surgery. To facilitate guidance of the instrument during the surgery, the estimated position of an instrument relative to the plurality of projection images can be displayed. The position of the instrument can be tracked using an electromagnetic (EM) tracking system, which uses ...
Published: 9/8/2015   |   Inventor(s): George Baker, David Kwartowitz, Fuad Mefleh
Keywords(s): cardiovascular, devices
Category(s): Device
MUSC Neurology Therapeutics
MUSC Neurology Therapeutics: Therapeutics for Epilepsy and other Neurological Disordershttp://musc.technologypublisher.com/technology/12246 Compounds for Induction of Mitochondrial Biogenesishttp://musc.technologypublisher.com/technology/12247 Nucleosides Analogs for Cardiovascular and Neurodegenerative Diseaseshttp://musc.technologypublisher.com/t...
Published: 2/13/2015   |   Inventor(s):  
Keywords(s): cardiovascular, neurological, renal
Category(s): Therapeutic
MUSC Fibrosis Therapeutics
MUSC Fibrosis Therapeutics Anti-Fibrotic Peptidehttp://musc.technologypublisher.com/technology/15216 A Novel Composition for Wound Healing and Tissue Repairhttp://musc.technologypublisher.com/technology/9562 Peptide for Treatment and Reversal of Fibrosishttp://musc.technologypublisher.com/technology/18231 Cardiac Repair Therapyhttp://musc.technolog...
Published: 2/9/2015   |   Inventor(s):  
Keywords(s): cardiovascular, wound care
Category(s): Therapeutic
Biomarkers for Detecting Diastolic Heart Failure
The inventors have developed a panel of biomarkers, including various matrix metalloproteinases (MMPs) and tissue inhibitor matrix metalloproteinases (TIMPs), which identifies patients with early-stage changes that are indicative of heart failure. These biomarkers can be detected and measured by performing a simple, point-of-care blood test and pro...
Published: 2/25/2013   |   Inventor(s): Francis Spinale, Robert Stroud, Michael Zile
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
Predicting Left Ventricular Dilation following Myocardial Infarction by Protease and Protease Inhibitor Profiling
This invention relates to a method of predicting diastolic heart failure in a patient, by identifying, from their body fluid, a profile of MMPs and TIMPs that is associated with the development of left ventricular dilation (LVD). This biomarker panel can identify these patients shortly (1-5 days) after their infarct occurs.Overview:Worldwide, more ...
Published: 2/25/2013   |   Inventor(s): Francis Spinale, Robert Stroud, Michael Zile
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
Biomarkers for Detecting and Monitoring Aortic Aneurysms
The inventors have developed a highly specific and sensitive panel of biomarkers, including various matrix metalloproteinases (MMPs) and tissue inhibitor matrix metalloproteinases (TIMPs), which identifies and follows the progression of thoracic aortic aneurysm in patients. These biomarkers can be detected and measured by performing a simple, point...
Published: 2/18/2013   |   Inventor(s): John Ikonomidis, Jeffrey Jones, Rupak Mukherjee, Robert Stroud, Michael Zile
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
Accurate Lesion Size Measurements during Cardiac Radiofrequency Catheter Ablation
Inventors have developed a radiofrequency ablation (RFA) system, which more accurately estimates lesion size in effort to preserve tissue will be affected during a procedure. The system quantifies blood convection cooling at the cardiac RF catheter ablation site and allows for prediction of lesion size and/or computation of RF energy parameters and...
Published: 6/15/2012   |   Inventor(s): Dieter Haemmerich, J. Philip Saul
Keywords(s): cardiovascular
Category(s): Software
Plasma Biomarkers for Predicting Recurrence of Atrial Fibrillation Following Cardioversion
The inventors have developed a panel of biomarkers, including various matrix metalloproteinases (MMPs) and tissue inhibitor matrix metalloproteinases (TIMPs), which can determine patients at risk for recurrent atrial fibrillation (AF). These biomarkers can pre-emptively detect treatment failure for cardioversion activities. These biomarkers can be ...
Published: 6/12/2012   |   Inventor(s): Rupak Mukherjee, Michael Gold, Francis Spinale
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
Assessing Left Ventricular Remodeling via Temporal Detection and Measurement of microRNA in Body Fluids
This invention provides a method of assessing cardiac disease including thoracic aortic aneurysm (TAA) and left ventricular (LV) remodeling by measuring the levels of 5 microRNAs (miRs) in a body fluid such as plasma or serum, or in cardiac and aortic tissue. miRs are small noncoding RNAs that recognize and bind to mRNA and inhibit protein translat...
Published: 3/8/2012   |   Inventor(s): Francis Spinale, Michael Zile, Robert Stroud
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
Biomarkers for the Detection and Monitoring of Coronary Artery Disease
The inventors have developed a methodology that has been robustly validated (~800 patients) to accurately and reliably measure Ox-LDL, AGE-LDL and other modified LDLs circulating in bound/immune-complex (IC) form. The method involves isolation of IC from blood samples and fractionation of the isolated IC in order to separate modified forms of LDL t...
Published: 4/19/2011   |   Inventor(s): Maria Lopes-Virella, Gabriel Virella
Keywords(s): cardiovascular, diagnostic
Category(s): Diagnostic
© 2018. All Rights Reserved. Powered by Inteum